Key result
Cardiac rehabilitation in young patients with nonischemic dilated cardiomyopathy was safe with no adverse events and increased 6-minute walk distance by a mean of 111 m (95% CI, 18-205).
Why the study?
Does cardiac rehabilitation improve cardiometabolic health and safety in young patients with nonischemic dilated cardiomyopathy?
Population
8 young patients with nonischemic dilated cardiomyopathy, AHA class C or D heart failure on maximal medical…
Design
Case_series
Follow-up
up to 1 year
Authors
Loading...
Hypothesis-generating for cardiac rehabilitation in young nonischemic dilated cardiomyopathy; larger trials needed before practice change.
Observational (n=8)
No
Does cardiac rehabilitation improve cardiometabolic health and safety in young patients with nonischemic dilated cardiomyopathy?
Effect estimate: Mean increase 111 m (95% CI 18-205)
Cardiac rehabilitation is feasible, safe, and associated with improved functional capacity and waist circumference in young patients with severe nonischemic dilated cardiomyopathy.
Wittekind et al. (2018) conducted an observational in Nonischemic dilated cardiomyopathy (n=8). Cardiac rehabilitation was evaluated on 6-minute walk distance (Mean increase 111 m, 95% CI 18-205). Cardiac rehabilitation in young patients with nonischemic dilated cardiomyopathy was safe with no adverse events and increased 6-minute walk distance by a mean of 111 m (95% CI, 18-205).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: